The aim of this procurement is to execute a project to support the development of advanced in vitro and in silico ADME (absorption, distribution, metabolism and excretion) models and databases for next generation risk assessment (NGRA) of chemicals using illustrative case studies.

Extended TitleADME4NGRA: Implementing the EFSA NAMs Roadmap through Advancing Toxicokinetic Knowledge in Chemical Risk Assessment
Extended Description

The recently completed EFSA Roadmap on new approach methodologies (NAMs) recommended toxicokinetics as a priority topic for further development in order to implement the NAMs roadmap. This proposal is in line with EFSA’s strategy 2027 specifying the development and integration of advanced NAMs in regulatory assessment as one of the Authority’s key scientific objectives. This procurement aims at promoting the development of advanced in vitro and in silico ADME models and databases through case studies and explore their use in developing quantitative in vitro to in vivo extrapolation (QIVIVE) and physiologically-based kinetic (PB-K) models for next generation risk assessment (NGRA) of chemicals.

The assays and data generated from this call are foreseen to provide valuable new tools to EFSA for the identification of potentially hazardous substances based on their ADME profiles and establishing a future practical platform for reliable and accurate application of NGRA for food/feed-relevant substances. Furthermore, deliverables from this procurement will enhance EFSA’s current risk assessment activities by evaluating the relevance of historical animal data to human health, reduce animal testing and support the prediction of chemical fate following food intake.

The procurement has the following three main objectives with regards to design, development and implementation of ADME data/assays in NGRA:

— Objective 1: Advanced in vitro systems for humans and rats to investigate ADME processes,

— Objective 2: Advanced in silico models and databases to depict ADME processes,

— Objective 3: Integrating QIVIVE and PB-K models in human risk assessment.

Deadline Date2022-09-15
Publication Date2022-06-22
CountryItaly
Procurement StatusActive
TypeOpen procedure
Contract TypeServices
Award CriteriaThe most economic tender
Value3000000.00
OrganisationEuropean Food Safety Authority (EFSA)
AddressVia Carlo Magno 1A
TownParma
Postal Code43126
Class Code73000000
Class DescriptionResearch and development services and related consultancy services
SourceOffice for Official Publications of the European Communities - Tenders electronic daily (Ted)

Version of 2022-05-13

ADME4NGRA: Implementing the EFSA New Approach Methodologies (NAMs) Roadmap through Advancing Toxicokinetic Knowledge in Chemical Risk Assessment

The aim of this procurement is to execute a project to support the development of advanced in vitro and in silico ADME (absorption, distribution, metabolism and excretion) models and databases for next generation risk assessment (NGRA) of chemicals using illustrative case studies.

Extended TitleADME4NGRA: Implementing the EFSA New Approach Methodologies (NAMs) Roadmap through Advancing Toxicokinetic Knowledge in Chemical Risk Assessment
Extended Description

The recently completed EFSA Roadmap on new approach methodologies (NAMs) recommended toxicokinetics as a priority topic for further development in order to implement the NAMs roadmap. This proposal is in line with EFSA’s strategy 2027 specifying the development and integration of advanced NAMs in regulatory assessment as one of the Authority’s key scientific objectives. This procurement aims at promoting the development of advanced in vitro and in silico ADME models and databases through case studies and explore their use in developing quantitative in vitro to in vivo extrapolation (QIVIVE) and physiologically-based kinetic (PB-K) models for next generation risk assessment (NGRA) of chemicals.

The assays and data generated from this call are foreseen to provide valuable new tools to EFSA for the identification of potentially hazardous substances based on their ADME profiles and establishing a future practical platform for reliable and accurate application of NGRA for food/feed-relevant substances. Furthermore, deliverables from this procurement will enhance EFSA’s current risk assessment activities by evaluating the relevance of historical animal data to human health, reduce animal testing and support the prediction of chemical fate following food intake.

The procurement has the following three main objectives with regards to design, development and implementation of ADME data/assays in NGRA:

— Objective 1: advanced in vitro systems for humans and rats to investigate ADME processes;

— Objective 2: advanced in silico models and databases to depict ADME processes;

— Objective 3: integrating QIVIVE and PB-K models in human risk assessment.

Publication Date2022-05-13
CountryItaly
Procurement StatusFuture
TypeNot applicable
Contract TypeServices
Award CriteriaNot applicable
Value3000000.00
OrganisationEuropean Food Safety Authority (EFSA)
AddressVia Carlo Magno 1A
TownParma
Postal Code43126
Class Code73000000
Class DescriptionResearch and development services and related consultancy services
SourceOffice for Official Publications of the European Communities - Tenders electronic daily (Ted)

Related Procurements

Deadline: Jul 25, 2022
Framework contract for the provision of maintenance services for analytical instruments (Perkin Elmer) in scientific laboratories at the JRC Ispra site.
View more
Deadline: Sep 6, 2022
La concessione ha per oggetto la realizzazione di lavori pubblici di ristrutturazione e/o di adeguamento di parte di complesso immobiliare, da realizzarsi con investimenti totalmente privati e senza oneri finanziari...
View more
Deadline: Aug 17, 2022
Affidamento della progettazione definitiva, esecutiva, coordinamento alla sicurezza in fase di progettazione ed esecuzione dei lavori
View more